Now researchers at Case Western Reserve University have developed a method to detect inflammation using antibodies, potentially leading to blood tests for disease-specific biomarkers such as for heart disease, Alzheimer’s disease and various cancers. Their breakthrough also holds promise for drug discovery.

Tissue processing advance can label proteins at the level of individual cells across large samples just as fast and uniformly as in dissociated single cells.

ATLANTA, Feb. 5, 2025 /PRNewswire/ — Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the US Food and Drug Administration (FDA) has cleared the SANSA home sleep apnea test to begin using cellular data upload capabilities. This breakthrough eliminates the need for Bluetooth pairing or smartphone apps commonly required to transmit test data to physicians, addressing a common source of failed home testing, while simplifying the diagnostic process for patients and providers alike.

Despite its advantages, laparoscopic surgery remains largely inaccessible in low- and middle-income countries (LMICs) due to the high cost of equipment and other logistical challenges. To bridge this gap, researchers recently developed the KeyScope, an affordable laparoscope designed specifically for LMICs. As reported in Biophotonics Discovery, the KeyScope system was developed through an iterative human-centered design approach.

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia—a bulge that results from soft tissue pushing through a weak spot in the abdominal muscles. Although common, the cause of these hernias is unknown, and the only treatment is surgery to repair the weakened area. Even after surgery, these hernias recur in 10 to 15% of men.

Elon Musk wants to merge humans with AI. And his goal of achieving “symbiosis” with artificial intelligence starts with a brain chip.

A DGIST research team, led by Professor Kyung-In Jang, has developed a smart patch capable of real-time biometric signal monitoring and drug delivery. This patch integrates various sensors and a drug delivery system into a single unit using a foldable structure, enabling real-time cardiovascular health monitoring and immediate drug administration when necessary. The research team expects this technology to be widely applicable across multiple medical fields, including glucose management, pain relief, and chronic disease treatment.

RapidAI announced that it received FDA 510(k) clearance for its Lumina 3D automated 3D imaging reconstruction solution.